Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
51
pubmed:dateCreated
2002-12-17
pubmed:abstractText
The bacterial potassium channel, KcsA, can be modified to express a high-affinity receptor site for the scorpion toxin kaliotoxin (KTX) by substituting subregion I in the P region of KcsA with the one present in the human voltage-gated potassium channel Kv1.3 [Legros, C., Pollmann, V., Knaus, H. G., Farrell, A. M., Darbon, H., Bougis, P. E., Martin-Eauclaire, M. F., and Pongs, O. (2000) J. Biol. Chem. 275, 16918-16924]. This approach opened the way to investigate whether sequence differences in subregion I of Kv1 channels correlate with the distinct pharmacological profiles of peptide inhibitors. A panel of six chimeras between KcsA and human Kv1.1-6 were constructed, expressed in Escherichia coli, purified to homogeneity, and assessed in filter binding assays using either monoiodo-tyrosine-KTX ([(125)I]KTX) or monoiodo-tyrosine-hongotoxin(1)(A19Y/Y37F) ([(125)I]HgTX(1)(A19Y/Y37F)). The KcsA-Kv1.X chimeras were found to have lower affinities for these ligands than the corresponding mammalian Kv1.X channels, indicating that other parts of the channels may contribute to binding or that subtle structural differences exist between these channels. The properties of the KcsA-Kv1.X chimeras were also characterized in surface plasmon resonance experiments. KcsA-Kv1.3 chimeras were immobilized on the surface of a sensor chip for determining, in real time, binding of the peptides. KTX binding properties to immobilized KcsA-Kv1.3 chimera were similar to those determined by filtration techniques. Taken together, our results demonstrate that the pharmacological profile of peptide toxins can be incorporated into KcsA-Kv1.X chimeras containing the subregion I of the corresponding mammalian Kv1.X channels. This innovative approach may facilitate the high-throughput screening of ligand libraries aimed at the discovery of novel potassium channel modulators.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alanine, http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Delayed Rectifier Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/KCNA1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/KCNA2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/KCNA3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Kv1.1 Potassium Channel, http://linkedlifedata.com/resource/pubmed/chemical/Kv1.2 Potassium Channel, http://linkedlifedata.com/resource/pubmed/chemical/Kv1.3 Potassium Channel, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Phenylalanine, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channels, Voltage-Gated, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Scorpion Venoms, http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine, http://linkedlifedata.com/resource/pubmed/chemical/hongotoxin 1, http://linkedlifedata.com/resource/pubmed/chemical/prokaryotic potassium channel
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15369-75
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12484776-Alanine, pubmed-meshheading:12484776-Amino Acid Sequence, pubmed-meshheading:12484776-Amino Acid Substitution, pubmed-meshheading:12484776-Animals, pubmed-meshheading:12484776-Bacterial Proteins, pubmed-meshheading:12484776-Binding Sites, pubmed-meshheading:12484776-Delayed Rectifier Potassium Channels, pubmed-meshheading:12484776-Humans, pubmed-meshheading:12484776-Kv1.1 Potassium Channel, pubmed-meshheading:12484776-Kv1.2 Potassium Channel, pubmed-meshheading:12484776-Kv1.3 Potassium Channel, pubmed-meshheading:12484776-Molecular Sequence Data, pubmed-meshheading:12484776-Mutagenesis, Site-Directed, pubmed-meshheading:12484776-Peptide Fragments, pubmed-meshheading:12484776-Phenylalanine, pubmed-meshheading:12484776-Potassium Channel Blockers, pubmed-meshheading:12484776-Potassium Channels, pubmed-meshheading:12484776-Potassium Channels, Voltage-Gated, pubmed-meshheading:12484776-Protein Structure, Tertiary, pubmed-meshheading:12484776-Recombinant Fusion Proteins, pubmed-meshheading:12484776-Scorpion Venoms, pubmed-meshheading:12484776-Surface Plasmon Resonance, pubmed-meshheading:12484776-Tyrosine
pubmed:year
2002
pubmed:articleTitle
Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
pubmed:affiliation
Institut für Neurale Signalverarbeitung, ZMNH, Universität Hamburg, Martinistrasse 52, D-20246 Hamburg, Germany. christian.legros@chimie.univ-evry.fr
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't